1. Home
  2. DY vs HALO Comparison

DY vs HALO Comparison

Compare DY & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dycom Industries Inc.

DY

Dycom Industries Inc.

HOLD

Current Price

$410.31

Market Cap

10.4B

Sector

Industrials

ML Signal

HOLD

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$70.11

Market Cap

8.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DY
HALO
Founded
1969
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Water Sewer Pipeline Comm & Power Line Construction
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.4B
8.8B
IPO Year
1995
2001

Fundamental Metrics

Financial Performance
Metric
DY
HALO
Price
$410.31
$70.11
Analyst Decision
Strong Buy
Buy
Analyst Count
10
11
Target Price
$425.30
$78.18
AVG Volume (30 Days)
362.6K
1.2M
Earning Date
05-20-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
20.71
N/A
EPS
9.56
2.56
Revenue
N/A
$151,862,000.00
Revenue This Year
$30.96
$28.24
Revenue Next Year
$9.49
$12.56
P/E Ratio
$41.85
$27.11
Revenue Growth
N/A
N/A
52 Week Low
$150.29
$47.50
52 Week High
$445.53
$82.22

Technical Indicators

Market Signals
Indicator
DY
HALO
Relative Strength Index (RSI) 67.07 61.36
Support Level $331.58 $67.94
Resistance Level $445.53 $71.53
Average True Range (ATR) 13.33 1.87
MACD 6.32 0.78
Stochastic Oscillator 96.15 94.03

Price Performance

Historical Comparison
DY
HALO

About DY Dycom Industries Inc.

Dycom Industries Inc is a provider of specialty contracting services to the telecommunications infrastructure and utility industries throughout the United States. The company has two reporting segments: Communications and Building Systems. The Communications segment provides specialty contracting services, including program management, planning; engineering and design; aerial, underground, and wireless construction; maintenance; and fulfillment services for telecommunications and digital infrastructure providers. The Building Systems segment specializes in providing comprehensive building infrastructure solutions, including electrical, energy management, security, and fire safety systems for data centers and other critical facilities. The firm generates key revenue from Communications.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: